Pin on PinterestShare on LinkedInTweet about this on TwitterShare on Facebook

Company Profile & Expertise

Our offer Specialized in clinical trials, development, conversion, and production of dry-form proprietary medications, as well as offering a concrete expertise of the PMA/MMA for-hospital-use, registered medical product (POD), generic, nutraceutical and cosmetic markets.

Specialist in small and middle batch sizes (Batch from 5 000 to 100 000 sale units).

  • Pharmaceutical development – GMP site measuring 10,000 m² and nutraceutical site measuring 1,200 m²
  • Project management: capable and versatile team, traceability and transparency – we employ a quality assurance system to every point in the process, guaranteeing the quality of your products.
  • Provision for industrial constraints as early as the formulation stage in order to facilitate transfer, scale-up and optimization of the cost of goods sold.
  • Technical expertise and consulting
  • Complete formulation and analysis of your product
  • Rapid production development and launch – GANTT project management method.

Our customers are spread over 3 continents:

Africa

New-Zealand

Cyprus

Australia

Malta

Maghreb

Spain

Portugal, Czech republic, Switzerland, Poland, Russia, Croatia…

SAS 880 000€ initial capital
RCS CLERMONT-FERRAND B 383 136 223
SIRET 383 136 223 00039
APE 2120Z
TVA FR03 383 136 223

1991  Founding-opening authorization at the ZI du Brezet industrial park (Clermont-Ferrand)

1995  Facilities moved to the site at Lempdes, 7 000m² opening authorization

2001  Nutraceutical  site  company acquires 2 200m² of additional production space (3 medium and high-output bottling lines)

2002  Company acquires its first Fette P1200

2004  Company acquires its second Fette P1200 (dry manufacturing area <3g/K – 20°C/20%)

2005  Company acquires a VS Coating 350 Kg machine (aqueous film coating

2007  Company acquires its third Fette P1200 (dry manufacturing area <3g/Kg – 20°C/ 20%)

2008  Expansion and installation of company’s second CAM line – € 1 million investment – dry manufacturing area
(<3g/ Kg – 20°C/ 20%)

2009  Expansion, Installation and emulsion process, vacuum microwave machine and a New GMP-grade Decontamination Facility (2 700m² €1.8 million  investment)

2012  Company acquires second Z40 capsule filling machine (€90K investment) & Z5

2015  Company acquires Kremer line